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Abstract: Sensing using specific and selective receptors provides two very different but 
complementary strategies. This Sensor Issues article will discuss the merits and challenges of 
specific sensors, and selective sensors based on synthetic arrays. We will examine where each 
has been successfully applied to a sensing challenge, and then look at how a combined 
approach could take elements of both to provide new sensor platforms. 
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Sensing approaches can broadly be split in to two silos: highly specific sensing, and array 
based selective sensing. The former is a sensor that in its ideal form would be completely 
specific to a single analyte, recognizing no other. This ideal is approached by antibodies, 
aptamers, and enzymatic lock-and-key or bio-conjugation pairs such as streptavidin/biotin.1,2 
Very often, however, this ideal is not achievable, due to high similarity between analytes or a 
lack of tools for specific sensing of the target. Selective sensing is often the best that can be 
achieved, and are quite useful, as demonstrated by the use of lectin arrays for selective glycan 
sensing. 3 
 
Sensors can also be engineered from the start to be selective. These systems are typically 
employed in an array-based format, where each sensing element interacts differentially with the 
analytes of interest, creating a fingerprint for that sample. The output of the array can be 
considered and processed as multidimensional data (multiple outputs from a single input), a 
feature facilitated through data analysis techniques.4 This array-based “chemical nose/tongue” 
approach has emerged from the world of chemometrics, gaining traction in the chemical sensor 
community in recent years.  
 
Many, if not most, of the sensors and tests in widespread use today rely on specific sensor 
elements for individual target analytes (e.g. biomarkers) and have had excellent success in the 
medical and bioscience domain. With the growth and success of cross-reactive, selective 
sensors, we believe that sensor design would benefit from combining the best of both sensing 
worlds when approaching a sensing challenge. 
 
In this Sensor Issues article we seek to compare and contrast the approaches of specific and 
selective array-based sensing, and show how overlap in these methodologies can be exploited 
to build better sensors. We will examine how to choose the best sensor type for the detection 
challenge at hand, and discuss where array based sensing may have a crucial role to play in an 
area typically dominated by specific sensors, whilst acting in tandem with the existing 
techniques, to provide a complete understanding of the system being examined. 
 
The Achievements of Specific Sensing 
 
Highly specific sensors based primarily on antibodies or enzymatic recognition, and in more 
recent years aptamer technology, have dominated the world of biosensing. In principle each 
single sensor constructed with this technology has a single target, and will bind no other, even 
in a complex sensing medium, such as blood serum, cell lysate or an environmental sample.5 
The success story of specific sensing is well known when it comes to commercialization; 
examples include antibodies used in lateral flow immunochromatographic assays (LFIA) for 
pregnancy testing,6 and glucose-specific enzymes contained in the blood glucose meters used 
by diabetics.7 
 
Specific sensing with antibodies has had a major impact on advancing the biosciences. 
Antibodies are the heart of the ELISA (enzyme linked immunosorbant assay)8 for proteomics 
screening and diagnosis of disease by sensing the up- and down-regulation of specific 
biomarkers, and associating them with pathologies. These assays have led to state of the art 
diagnostic tests for ailments such as liver fibrosis9 and cardiac disease.10 Beyond biomedicine, 
explosives,11 and drugs of abuse12 have likewise been successfully targeted using antibody-
embedded sensors.  
 
Antibodies are quite versatile, but are prone to denaturation and cannot recognize every 
analyte. Aptamers – short chains of nucleic acids or peptides that are engineered to have 
specific binding to a target molecule – are one such strategy that is now widely being used in 
the specific sensing domain.13 Such sensors have been applied to detection of numerous 
targets including proteins of the HIV virus,14 and small molecules such as sugars.15 Another 
example of ‘next gen’ recognition elements are modified viruses or ‘phages’ that have ben used 
for sensing peptides and proteins.16  
 
Single target specific sensing approaches are useful if one has a strong and simple hypothesis 
in mind related to one or two analytes, as in the above examples. However, the diagnosis of 
diseases can necessitate monitoring the levels of 4, up to 20+ different biomarkers,17 requiring a 
large array of antibodies in a sensor (Figure 1). These arrays work well to distinguish multiple 
components in the sample, generating a pattern that can be used to identify disease states. 
However, there is often incomplete knowledge of what biomarkers should even be targeted, 
while many diseases don’t have associated specific recognition elements currently available. 
 
Selectivity by necessity 
 
While specific and array based sensing present two distinct camps in the sensor community, 
there is an intermediate ground where selective sensors are employed simply because specific 
sensors are unavailable. One key example is the use of sugar-binding proteins, lectins, to sense 
carbohydrate containing biomolecules such as glycoproteins or glycolipids. Although having a 
high specificity for carbohydrates in general, individual lectins are not specific to individual 
glycosylated biomolecules. Thus, an array of lectins can be used in a single run to map the 
carbohydrates present.3 Another example is detection of a class of enzymes, mitogen-activated 
protein (MAP) kinases, in cell lysate or biological media, using an array of modified fluorescent 
substrates (SOX peptides).18 A single peptide substrate would give no information on the 
classes of kinases present, but by having an array of peptide substrates, a picture can be built 
up of the MAP kinases present upon analyzing the products produced. These examples of 
sensing arrays utilize multidimensional data analysis to leverage their cross-reactivity to give 
discriminatory information on the analytes present, providing output similar to both specific 
sensor arrays and engineered selective sensor platforms.  
 
 
 
 
Figure 1. The transition from specific to selective sensing, and the corresponding outputs that are 
generated by sensor designs: (a) an antibody gives specific information about a single analyte, due to its 
high specificity. (b) Multiple analytes require different antibodies, leading to the creation of an antibody 
array in which each array component is only specific to a single analyte with no cross-reactivity. (c) 
Selective sensor arrays likewise give rise to unique patterns (fingerprints) for each analyte due to the 
cross-reactivity of the array components. (d) Hypothesis free, cross-reactive arrays enable the 
differentiation of multiple analytes, even those of different types (organic, inorganic etc.), with no previous 
knowledge needed. In all three of the multi-sensor platforms patterns are generated that can be analyzed 
to match against a known pattern using statistical methods.  
Selectivity by design 
 
Selectivity and cross-reactivity are central features of olfaction, and can be used as a starting 
point for sensor design. Arrays can be designed using synthetic materials to target specific 
classes of analytes and introduce selectivity within the targets, exploiting advances in 
supramolecular chemistry to control analyte-sensor interactions, but without the need for the 
precise engineering of an antibody or aptamer (Figure 1). These sensor systems are 
enormously flexible; they are synthetically created from first principles, and therefore can consist 
of a wide variety of array types and methods to suit all sensing challenges. Through this 
synthetic approach, the sensor arrays can be designed to be tolerant to a wide variety of media, 
extremes of pH and of temperature. Sensor elements can also target a wide variety of 
biomolecules, small molecules or inorganic ions, all in the same test. 
 
Array based sensing generates rich, multidimensional information from a single experimental 
run. Therefore, detecting multiple analytes is achievable simultaneously, in a manner similar to 
olfaction. This gives rise to a ‘chemical nose/tongue’ that generates a unique pattern that can be 
tied back to the composition of the sample. There is no need for a large number of sensor 
elements to detect a large number of analytes,19 if the cross-reactivity is engineered well a few 
sensor elements can discriminate many more analytes.  
 
Careful selection of a suitable statistical approach allows maximal information on the sample to 
be gained, while avoiding biased results.20,21 In all cases, it is vitally important that separate 
training and test sets are generated to verify how the sensor performs in a real classification 
problem, rather than just being internally cross-validated. It is also beneficial to discover what 
interferrants or conditions may lead to sensor failure, to allow for future improvements.   
 
An advantage of array-based selective sensor approach is that if a new analyte/class of sample 
needs to be detected, few if any changes need to be made to the array. The pattern recognition 
library simply needs to be updated by re-training the array on known samples to recognize new 
analytes. Examples of these synthetic arrays have been widely researched for detecting small 
molecules, explosives, drugs of abuse and also biological samples such as proteins, cells and 
bacteria.22,23 An important issue with these sensors is that they give ‘fingerprints’ that do not 
readily measure multiple individual components within the whole sample, unlike the specific 
analyte data provided using parallel specific sensors. Thus, many of the examples listed here 
can be addressed with additional information content by the application of a specific sensing 
regime. 
 
When choosing a sensing approach, one must consider the particular advantages that selective 
array-based sensing can offer and where it might be more appropriate to use highly specific 
sensors. Specific sensors give direct information on biomarkers or other analytes that is often 
important in categorizing complex disease states or environmental samples. Selective arrays 
perform well when it comes to sensing the whole sample, not just its individual components. 
Therefore, such systems can be used in a hypothesis-less fashion. This is an enormously 
powerful approach in situations such as the earlier example of disease detection, where many 
biomarkers must be detected at once to confirm the disease, while some could possibly be 
unknown.  
 
Hypothesis-free universal sensors? 
 
Much of the work on array-based sensors has focused on detecting and differentiating single 
analytes in a complex sample, for example explosives in water samples, or single proteins in a 
serum sample.22,24 However, in these cases it may be more efficient to use a highly specific 
sensor, such as an antibody targeted to the analyte in question.25 A more powerful use of arrays 
is to target complex matrices, where all the analytes present may not be known. These 
applications include analyzing methods of drug action,26 atmospheric analysis to protect against 
toxic gasses,27 or sensing of disease for diagnosis and follow up.28 A selective array can 
operate in a hypothesis-less mode, where samples are discriminated based on their complete, 
selective interaction, rather than on the basis of any single component. A suitably cross-reactive 
array might be applicable to any number of these cases, for example the colorimetric arrays of 
Suslick et al.29 This advances the technology towards the idea of a ‘universal sensor’. 
 
It seems foolish, however, to perpetuate the siloing of specific and selective arrays. Integrating 
specific and selective sensor elements has the potential to provide synergy, and hence much 
more effective sensor platforms. For example, by introducing class specificity – limiting the 
selectivity of the sensor array within a group of particularly important analytes – such as in the 
case of lectin arrays, we can improve stability of the array and minimize the impact of changes 
in the sample background on the sensing response.  
 
A second area where specific and selective sensing are complimentary is in hypothesis-less 
testing for exploration of the underlying sensing mechanisms. A sample of a diseased patient 
will give a particular sensor response, different from a healthy patient, but understanding what 
components of the sample cause this difference unlocks information on the fundamentals of the 
disease itself and the mode of operation of the sensor array.30 
 
Conclusions 
 
Specific and selectivity-based strategies each have their place in the research community and in 
the world at large. Understanding the strengths and limitations of each provides a means of 
choosing the method that works best. Beyond choice of method, however, we suggest that 
elements of both approaches be incorporated into a new class of array-based sensors. Finally, 
we encourage array-based sensor researchers to consider applying specific sensors to their 
samples in tandem, and of course for researchers in the specific sensors camp to likewise 
consider selectivity-based enhancements.  
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